New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
CASI Pharmaceuticals Inc. (CASIF) vs Quantum Biopharma Ltd. (QNTM)
- CASI Pharmaceuticals Inc. CASIF 0.11 +10.00%
- Quantum Biopharma Ltd. QNTM 1.29 −9.15%
CASI Pharmaceuticals Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. CASI Pharmaceuticals Inc. and Quantum Biopharma Ltd. are of similar size ($12.6M and $12.4M). CASI Pharmaceuticals Inc. has the higher net margin (−232.0% vs −16,880.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, CASI Pharmaceuticals Inc. leads on 8 and Quantum Biopharma Ltd. on 5.
Valuation
Profitability
| Metric | CASIF | QNTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 48.65% | (1,068.29%) | 70.18% |
| Operating margin | (206.87%) | (9,699.83%) | 0.00% |
| Net margin | (232.03%) | (16,880.72%) | 0.00% |
| Free cash flow margin | — | (6,089.39%) | 0.00% |
| Return on equity | 271.28% | (233.09%) | (51.58%) |
| Return on assets | (121.17%) | (127.92%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack